Health In Tech (HIT) Competitors $0.61 -0.01 (-2.02%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock HIT vs. RDZN, ICCH, NEUE, ZBAO, AAME, FGF, HUIZ, OXBR, CNFR, and AIFUShould you be buying Health In Tech stock or one of its competitors? The main competitors of Health In Tech include Roadzen (RDZN), ICC (ICCH), NeueHealth (NEUE), Zhibao Technology (ZBAO), Atlantic American (AAME), Fundamental Global (FGF), Huize (HUIZ), Oxbridge Re (OXBR), Conifer (CNFR), and AIX (AIFU). These companies are all part of the "insurance" industry. Health In Tech vs. Roadzen ICC NeueHealth Zhibao Technology Atlantic American Fundamental Global Huize Oxbridge Re Conifer AIX Roadzen (NASDAQ:RDZN) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Which has preferable valuation and earnings, RDZN or HIT? Health In Tech has lower revenue, but higher earnings than Roadzen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoadzen$42.89M1.68-$99.67M-$1.51-0.64Health In Tech$22.38M1.48N/AN/AN/A Do analysts rate RDZN or HIT? Roadzen currently has a consensus price target of $5.00, indicating a potential upside of 416.90%. Given Roadzen's stronger consensus rating and higher probable upside, research analysts clearly believe Roadzen is more favorable than Health In Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roadzen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Health In Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer RDZN or HIT? Roadzen received 3 more outperform votes than Health In Tech when rated by MarketBeat users. CompanyUnderperformOutperformRoadzenOutperform Votes3100.00% Underperform VotesNo VotesHealth In TechN/AN/A Is RDZN or HIT more profitable? Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -248.79%. Company Net Margins Return on Equity Return on Assets Roadzen-248.79% N/A -269.99% Health In Tech N/A N/A N/A Do insiders & institutionals have more ownership in RDZN or HIT? 24.7% of Roadzen shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer RDZN or HIT? In the previous week, Health In Tech had 1 more articles in the media than Roadzen. MarketBeat recorded 3 mentions for Health In Tech and 2 mentions for Roadzen. Health In Tech's average media sentiment score of 0.62 beat Roadzen's score of 0.61 indicating that Health In Tech is being referred to more favorably in the news media. Company Overall Sentiment Roadzen Positive Health In Tech Positive SummaryRoadzen beats Health In Tech on 7 of the 11 factors compared between the two stocks. Get Health In Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for HIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIT vs. The Competition Export to ExcelMetricHealth In TechInsurance Agents, Brokers & Service IndustryFinance SectorNASDAQ ExchangeMarket Cap$33.15M$33.15M$11.13B$7.82BDividend YieldN/AN/A5.61%4.22%P/E RatioN/AN/A22.0018.48Price / Sales1.481.4826.02103.91Price / CashN/AN/A17.6234.62Price / BookN/AN/A2.664.25Net IncomeN/AN/A$1.03B$248.23M7 Day Performance-5.89%-2.95%1.27%3.29%1 Month Performance-10.79%-5.39%-0.74%2.43%1 Year PerformanceN/AN/A536.03%5.54% Health In Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HITHealth In TechN/A$0.61-2.0%N/AN/A$33.83M$22.38M0.0079Gap DownRDZNRoadzen2.0497 of 5 stars$1.07+7.8%$5.00+367.3%-76.7%$79.49M$42.89M-0.71324Short Interest ↓Gap UpICCHICCN/A$23.49flatN/AN/A$73.74M$93.57M10.5890Upcoming EarningsNEUENeueHealth1.6214 of 5 stars$6.40-1.8%$7.00+9.4%+7.6%$53.03M$936.66M-0.131,252Upcoming EarningsZBAOZhibao TechnologyN/A$0.93-8.7%N/A-66.9%$29.20M$245.79M0.00148Short Interest ↑Gap UpHigh Trading VolumeAAMEAtlantic American1.0413 of 5 stars$1.39+0.0%N/A-24.2%$28.32M$188.23M-3.97140Gap DownFGFFundamental Global1.0876 of 5 stars$15.38-0.9%N/A-50.7%$19.56M$28.64M11.749Short Interest ↑Gap UpHUIZHuize1.3187 of 5 stars$1.83+1.4%N/A-86.9%$18.15M$1.25B20.281,640Short Interest ↓OXBROxbridge Re2.5792 of 5 stars$1.44-4.6%N/A+27.7%$10.72M$546,000.00-1.713Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageGap DownCNFRConifer1.5888 of 5 stars$0.60-6.1%N/A-22.2%$7.36M$66.30M0.25150Positive NewsAIFUAIXN/A$0.13-5.5%N/AN/A$7.19M$2.36B0.175,780 Related Companies and Tools Related Companies Roadzen Competitors ICC Competitors NeueHealth Competitors Zhibao Technology Competitors Atlantic American Competitors Fundamental Global Competitors Huize Competitors Oxbridge Re Competitors Conifer Competitors AIX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HIT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health In Tech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health In Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIT Stock Free HIT Stock Alerts